PAR 5.77% 24.5¢ paradigm biopharmaceuticals limited..

Ann: Entitlement Offer and Placement Prospectus, page-16

  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    Good points. My prediction is if we don't sign a partnership deal in the next 6 months then this brings into play a possible buy out offer since PAR's P3 program could be in limbo.

    I also just re-read what is needed to achieve these incentives and the bar appears to be set very low. They just seem to be regular milestones. It would be nice to tie their employment to these milestones too.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.015(5.77%)
Mkt cap ! $85.70M
Open High Low Value Volume
26.0¢ 26.0¢ 24.5¢ $265.4K 1.050M

Buyers (Bids)

No. Vol. Price($)
8 130186 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 11571 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.